2025年基因開關全球市場報告

預計未來幾年基因開關市場將快速成長。到 2029 年，這一數字將成長至 15.8 億美元，複合年成長率為 14.1%。預測期內的成長歸因於個人化醫療需求的不斷成長、遺傳疾病患病率的上升、針對性癌症治療需求的不斷增加、全球健康計劃的不斷增加以及基因開關的使用不斷增加。預測期內的關鍵趨勢包括技術進步、基於 CRISPR 的基因開關、人工智慧的整合、採用基因開關進行基因靜默以及表觀遺傳基因開關。

預計未來遺傳疾病的盛行率不斷上升將推動基因轉換市場的發展。遺傳疾病源自於個體 DNA 異常，可由突變、遺傳基因改變或染色體異常所引起。遺傳疾病的增加很大程度上是由於人們認知的提高、診斷能力的增強、醫療保健的改善以及人口老化。基因開關透過精確控制基因表現，為治療這些疾病提供了顯著的優勢，從而促進了有針對性的有效治療方法的發展。例如，2023年9月，英國國家慈善機構囊性纖維化信託基金報告稱，英國登記的囊腫纖維化患者數量增加了240人，從2021年的10,908人增加到2022年的11,148人。因此，遺傳疾病發生率的上升正在推動基因轉換市場的成長。

個人化醫療的日益普及預計將推動基因轉換市場的擴張。個人化醫療涉及根據個人特徵（例如遺傳和生活習慣）量身定做治療，以提高療效並減少副作用。個人化醫療的興起受到更有效治療的潛力、基因組學的進步、疾病複雜性的增加以及支持性法規的推動。基因開關透過精確控制基因表現和根據個別基因圖譜制定個人化治療方法，在個人化醫療中發揮關鍵作用。例如，個人化醫療聯盟在 2024 年 2 月報告稱，FDA 在 2023 年核准了16 種新的罕見疾病個人化治療方法，高於 2022 年的 6 種。個人化醫療的日益普及正在推動基因轉換市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球基因轉換PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球基因轉換市場：成長率分析
• 全球基因開關市場表現：規模與成長，2019-2024
• 全球基因開關市場預測：規模與成長，2024-2029 年，2034 年
• 全球基因開關總目標市場（TAM）

第6章市場區隔

• 全球基因開關市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• CAR-T細胞療法
• 基因治療
• 其他治療方法
• 全球基因開關市場依支付模式分類，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 預付款
• 里程碑付款
• 全球基因開關市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 治療相關毒性的管理
• 基因表現調控
• 其他用途
• 全球基因開關市場 CAR-T 細胞療法細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• CD19靶向CAR-T細胞療法
• BCMA靶向CAR-T細胞療法
• CD22靶向CAR-T細胞療法
• 多抗原CAR-T細胞療法
• 下一代CAR-T細胞療法
• 全球基因轉換市場基因治療細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 基於腺病毒載體的基因治療
• 利用慢病毒載體進行基因治療
• AAV（腺結合病毒）基因治療
• CRISPR-Cas9基因編輯療法
• 基於RNA干擾的基因治療
• 全球基因開關市場其他治療方法細分市場（按類型、績效和預測），2019-2024 年、2024-2029 年、2034 年
• 幹細胞療法
• RNA療法
• 蛋白質替代療法
• 基因編輯技術
• 免疫治療方法

第7章 區域和國家分析

• 全球基因開關市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球基因開關市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 基因開關市場：競爭格局
• 基因開關市場：公司簡介
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis
  • bluebird bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Regenxbio Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Kite Pharma Inc.
• Genomatica Inc.
• Intellia Therapeutics Inc.
• Voyager Therapeutics Inc.
• Precigen Inc.
• Editas Medicine Inc.
• Cellectis SA
• Autolus Therapeutics plc
• aceRNA Technologies
• Cartherics Pty Ltd
• panCELLa Inc.
• Aptamer Group plc
• Bellicum Pharmaceuticals Inc.
• Genocea Biosciences Inc.
• CRISPR Therapeutics AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年基因開關市場：提供新機會的國家
• 2029 年基因開關市場：細分領域帶來新機會
• 2029 年基因開關市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

A gene switch is a molecular tool that can activate or deactivate genes or modulate their activity levels, allowing cells to adjust gene expression in response to various signals and environmental changes. Gene switches offer precise control over gene expression, facilitating targeted therapeutic treatments, advanced research endeavors, and enhanced biotechnology processes.

The primary types of gene switches include CAR T cell therapies, gene therapies, and other methods. CAR T cell therapies involve altering a patient's T cells, a type of immune cell, to express a receptor that targets cancer cells. The payment models for these therapies often include upfront payments and milestone payments, and they are used for managing treatment-related toxicity, regulating gene expression, and other therapeutic applications.

The gene switch market research report is one of a series of new reports from The Business Research Company that provides gene switch market statistics, including gene switch industry global market size, regional shares, competitors with a gene switch market share, detailed gene switch market segments, market trends, and opportunities, and any further data you may need to thrive in the gene switch industry. This gene switch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene switch market size has grown rapidly in recent years. It will grow from $0.82 $ billion in 2024 to $0.93 $ billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to the expansion of gene-based clinical trials, growth in regenerative medicine, increasing public awareness of genetic technologies, expansion of research in functional genomics, and increasing demand for genetic testing services.

The gene switch market size is expected to see rapid growth in the next few years. It will grow to $1.58 $ billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to rising demand for personalized medicine, rising prevalence of genetic disorders, rising need for targeted cancer therapies, rising global health initiatives, and increasing use of gene switches. Major trends in the forecast period include technological advancements, CRISPR-based gene switches, integration of AI, adoption of gene switches for gene silencing, and epigenetic gene switches.

The growing prevalence of genetic disorders is anticipated to boost the gene switch market in the future. Genetic disorders arise from abnormalities in an individual's DNA, which can result from mutations, inherited genetic changes, or chromosomal anomalies. This increase in genetic disorders is largely due to greater awareness, enhanced diagnostic capabilities, better healthcare, and an aging population. Gene switches offer a significant advantage in managing these disorders by allowing precise control over gene expression, thereby fostering the development of targeted and effective treatments. For instance, in September 2023, the Cystic Fibrosis Trust, a UK-based national charity, reported an increase in registered cystic fibrosis patients in the UK from 10,908 in 2021 to 11,148 in 2022, marking a rise of 240 patients. Consequently, the increasing incidence of genetic disorders is fueling growth in the gene switch market.

The growing adoption of personalized medicine is expected to drive the expansion of the gene switch market. Personalized medicine customizes medical treatments based on individual characteristics, such as genetics or lifestyle, to enhance effectiveness and reduce adverse effects. The rise in personalized medicine is propelled by its potential for more effective treatments, advances in genomics, the increasing complexity of diseases, and supportive regulations. Gene switches play a key role in personalized medicine by providing precise control over gene expression, facilitating tailored therapeutic approaches based on individual genetic profiles. For example, the Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. This growing adoption of personalized medicine is driving the gene switch market.

In January 2023, Autolus Therapeutics, a biopharmaceutical company based in the UK, partnered with Cabaletta Bio to incorporate Autolus' RQR8 safety switch system into cell therapies aimed at autoimmune diseases. This collaboration aims to enhance the safety and effectiveness of these therapies. Cabaletta Bio, a US-based biotechnology company, is involved in developing cell therapies.

Major companies operating in the gene switch market are Bristol-Myers Squibb Company, Novartis AG, Charles River Laboratories International Inc, bluebird bio Inc., Regenxbio Inc., Kite Pharma Inc., Genomatica Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., Precigen Inc., Editas Medicine Inc., Cellectis SA, Autolus Therapeutics plc, aceRNA Technologies, Cartherics Pty Ltd, panCELLa Inc., Aptamer Group plc, Bellicum Pharmaceuticals Inc., Genocea Biosciences Inc., CRISPR Therapeutics AG

North America was the largest region in the gene switch market in 2023. The regions covered in the gene switch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene switch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene switch market consists of revenues earned by entities by providing services such as gene regulation services, custom gene synthesis, research and development services, consulting, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene switch market also includes sales of synthetic gene constructs, gene switch kits, regulatory proteins and small molecules, delivery systems, assay systems, software, and bioinformatics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Switch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene switch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene switch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene switch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: CAR T Cell Therapies; Gene Therapies; Other Therapies
• 2) By Payment Model Employed: Upfront Payments; Milestone Payments
• 3) By Application Area: Management Of Treatment Related Toxicity; Regulation Of Gene Expression; Other Applications
• Subsegments:
• 1) By CAR T Cell Therapies: CD19-Targeted CAR T Cell Therapies; BCMA-Targeted CAR T Cell Therapies; CD22-Targeted CAR T Cell Therapies; Multi-Antigen CAR T Cell Therapies; Next-Generation CAR T Cell Therapies
• 2) By Gene Therapies: Adenoviral Vector-Based Gene Therapies; Lentiviral Vector-Based Gene Therapies; AAV (Adeno-Associated Virus) Gene Therapies; CRISPR-Cas9 Gene Editing Therapies; RNA Interference-Based Gene Therapies
• 3) By Other Therapies: Stem Cell Therapies; RNA Therapy; Protein Replacement Therapy; Gene Editing Technologies; Immunotherapy Approaches
• Companies Mentioned: Bristol-Myers Squibb Company; Novartis AG; Charles River Laboratories International Inc; bluebird bio Inc.; Regenxbio Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Switch Market Characteristics

3. Gene Switch Market Trends And Strategies

4. Gene Switch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gene Switch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Switch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Switch Market Growth Rate Analysis
• 5.4. Global Gene Switch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Switch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Switch Total Addressable Market (TAM)

6. Gene Switch Market Segmentation

• 6.1. Global Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAR T Cell Therapies
• Gene Therapies
• Other Therapies
• 6.2. Global Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upfront Payments
• Milestone Payments
• 6.3. Global Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Management Of Treatment Related Toxicity
• Regulation Of Gene Expression
• Other Applications
• 6.4. Global Gene Switch Market, Sub-Segmentation Of CAR T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CD19-Targeted CAR T Cell Therapies
• BCMA-Targeted CAR T Cell Therapies
• CD22-Targeted CAR T Cell Therapies
• Multi-Antigen CAR T Cell Therapies
• Next-Generation CAR T Cell Therapies
• 6.5. Global Gene Switch Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adenoviral Vector-Based Gene Therapies
• Lentiviral Vector-Based Gene Therapies
• AAV (Adeno-Associated Virus) Gene Therapies
• CRISPR-Cas9 Gene Editing Therapies
• RNA Interference-Based Gene Therapies
• 6.6. Global Gene Switch Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapies
• RNA Therapy
• Protein Replacement Therapy
• Gene Editing Technologies
• Immunotherapy Approaches

7. Gene Switch Market Regional And Country Analysis

• 7.1. Global Gene Switch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Switch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Switch Market

• 8.1. Asia-Pacific Gene Switch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Switch Market

• 9.1. China Gene Switch Market Overview
• 9.2. China Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Switch Market

• 10.1. India Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Switch Market

• 11.1. Japan Gene Switch Market Overview
• 11.2. Japan Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Switch Market

• 12.1. Australia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Switch Market

• 13.1. Indonesia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Switch Market

• 14.1. South Korea Gene Switch Market Overview
• 14.2. South Korea Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Switch Market

• 15.1. Western Europe Gene Switch Market Overview
• 15.2. Western Europe Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Switch Market

• 16.1. UK Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Switch Market

• 17.1. Germany Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Switch Market

• 18.1. France Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Switch Market

• 19.1. Italy Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Switch Market

• 20.1. Spain Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Switch Market

• 21.1. Eastern Europe Gene Switch Market Overview
• 21.2. Eastern Europe Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Switch Market

• 22.1. Russia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Switch Market

• 23.1. North America Gene Switch Market Overview
• 23.2. North America Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Switch Market

• 24.1. USA Gene Switch Market Overview
• 24.2. USA Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Switch Market

• 25.1. Canada Gene Switch Market Overview
• 25.2. Canada Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Switch Market

• 26.1. South America Gene Switch Market Overview
• 26.2. South America Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Switch Market

• 27.1. Brazil Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Switch Market

• 28.1. Middle East Gene Switch Market Overview
• 28.2. Middle East Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Switch Market

• 29.1. Africa Gene Switch Market Overview
• 29.2. Africa Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Switch Market Competitive Landscape And Company Profiles

• 30.1. Gene Switch Market Competitive Landscape
• 30.2. Gene Switch Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. bluebird bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regenxbio Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Switch Market Other Major And Innovative Companies

• 31.1. Kite Pharma Inc.
• 31.2. Genomatica Inc.
• 31.3. Intellia Therapeutics Inc.
• 31.4. Voyager Therapeutics Inc.
• 31.5. Precigen Inc.
• 31.6. Editas Medicine Inc.
• 31.7. Cellectis SA
• 31.8. Autolus Therapeutics plc
• 31.9. aceRNA Technologies
• 31.10. Cartherics Pty Ltd
• 31.11. panCELLa Inc.
• 31.12. Aptamer Group plc
• 31.13. Bellicum Pharmaceuticals Inc.
• 31.14. Genocea Biosciences Inc.
• 31.15. CRISPR Therapeutics AG

32. Global Gene Switch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Switch Market

34. Recent Developments In The Gene Switch Market

35. Gene Switch Market High Potential Countries, Segments and Strategies

• 35.1 Gene Switch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Switch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Switch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer